SCHEMBL4683182

SCHEMBL4683182

CC(=O)OC(C)CC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.57
TSHR P16473 2/20 0.52
CHRM2 P08172 1/20 0.52
CHRM4 P08173 1/20 0.52
CHRM1 P11229 1/20 0.52
TBXA2R P21731 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.50
GALR3 O60755 1/20 0.50
MAPT P10636 1/20 0.50
BLM P54132 1/20 0.50
LMNA P02545 1/20 0.48
SLC22A6 Q4U2R8 1/20 0.38
MMP12 P39900 1/20 0.38
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CACNA2D1 P54289 2/20 0.35
CACNB3 P54284 1/20 0.35
CACNA1C Q13936 1/20 0.35
PGR P06401 1/20 0.35
ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10309227 1.00 ALOX15 (0.57) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL23499667 0.82 ALOX15 (0.50) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL7249516 0.82 TSHR (0.54) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL1268762 0.82 SLC22A6 (0.39) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL5949295 0.82 TSHR (0.54) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL18096461 0.81 ALOX15 (0.39) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL14401391 0.81 ALOX15 (0.48) ALOX15TSHRCHRM2CHRM4CHRM1
Ammonia Solution, Strong SCHEMBL9958331 0.80 TDP1 (0.42) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL18526466 0.78 LMNA (0.54) ALOX15TSHRCHRM2CHRM4CHRM1
SCHEMBL8862295 0.78 ALOX15 (0.36) ALOX15TSHRCHRM2CHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113508105-A Process for producing fatty alcohol esters of hydroxycarboxylic acids IOI油脂化学品有限责任公司 2021-10-15 CN claimed
EP-3880642-A1 METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXY CARBOXYLIC ACIDS IOI Oleo GmbH (DE) 2021-09-22 EP claimed
WO-2020147982-A1 METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXY CARBOXYLIC ACIDS IOI OLEO GMBH (DE) 2020-07-23 WO claimed
WO-2020002136-A1 CATALYST BASED ON A BETA-SUBSTITUTED ESTER AND USE THEREOF IN A HYDROTREATMENT AND/OR HYDROCRACKING PROCESS IFP Energies Nouvelles (FR) 2020-01-02 WO claimed
US-5695909-A Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1997-12-09 US claimed
WO-2026037224-A1 METHOD AND COMPOSITION FOR INCREASING OR MAINTAINING KETONE BODY LEVELS AND IMPROVING METABOLIC FUNCTIONS 南京纽邦生物科技有限公司 2026-02-19 WO disclosed
US-12365645-B2 Method for producing fatty alcohol esters of hydroxycarboxylic acids KETOLIPIX THERAPEUTICS GMBH (DE) 2025-07-22 US disclosed
CN-113508105-B Method for producing fatty alcohol esters of hydroxycarboxylic acids 凯托利皮克斯治疗有限责任公司 2025-02-28 CN disclosed
CN-119330830-A Method for producing fatty alcohol esters of hydroxycarboxylic acids 凯托利皮克斯治疗有限责任公司 2025-01-21 CN disclosed
US-20240327330-A1 METHOD FOR PRODUCING LIPIDS COMPRISING STRUCTURAL UNITS BASED ON GLYCERIDES OF HYDROXYCARBOXYLIC ACIDS KETOLIPIX THERAPEUTICS GMBH (DE) 2024-10-03 US disclosed
US-12091383-B2 Method for producing lipids comprising structural units based on glycerides of hydroxycarboxylc acids KETOLIPIX THERAPEUTICS GMBH (DE) 2024-09-17 US disclosed
US-20240294456-A1 METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXYCARBOXYLIC ACIDS KETOLIPIX THERAPEUTICS GMBH (DE) 2024-09-05 US disclosed
EP-1685102-A4 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCES LTD (KR) 2008-08-20 EP disclosed
EP-1685102-A1 MELANOCORTIN RECEPTOR AGONISTS LG Life Sciences Ltd. (KR) 2006-08-02 EP disclosed
WO-2005047251-A1 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCES LTD. (KR) 2005-05-26 WO disclosed
US-5695909-A Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1997-12-09 US disclosed
US-5665887-A Methine compound FUJI PHOTO FILM CO., LTD. (JP) 1997-09-09 US disclosed
EP-0313379-B1 OPTICALLY ACTIVE COMPOUND HAVING DELTA-VALEROLACTONE RING AND LIQUID CRYSTAL COMPOSITION COMPRISING SAME MITSUBISHI RAYON CO., LTD. (JP) 1992-07-22 EP disclosed
US-5045228-A Useful for high speed print heads MITSUBISHI RAYON COMPANY LTD. (JP) 1991-09-03 US disclosed
EP-0313379-A2 Optically active compound having delta-valerolactone ring and liquid crystal composition comprising same MITSUBISHI RAYON CO., LTD. (JP) 1989-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12365645-B2 Method for producing fatty alcohol esters of hydroxycarboxylic acids FASN, HSD17B12, SCD ALOX15 66/4885TSHR 2979/4885CHRM2 3613/4885
US-12091383-B2 Method for producing lipids comprising structural units based on glycerides of hydroxycarboxylc acids LIPC, MGLL, ACACB ALOX15 220/4885TSHR 3779/4885CHRM2 3924/4885
US-20240327330-A1 METHOD FOR PRODUCING LIPIDS COMPRISING STRUCTURAL UNITS BASED ON GLYCERIDES OF HYDROXYCARBOXYLIC ACIDS FASN, MGLL, LIPC ALOX15 110/4885TSHR 3708/4885CHRM2 4002/4885
US-20240294456-A1 METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXYCARBOXYLIC ACIDS FASN, HSD17B12, SCD ALOX15 66/4885TSHR 2979/4885CHRM2 3613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.